BIO-RAD LABORATORIES, INC. 8-K

What Happened

• Bio‑Rad Laboratories, Inc. filed a Form 8‑K on February 12, 2026 (Items 2.02, 7.01 and 9.01) announcing its financial results for the quarter ended December 31, 2025.
• The company furnished a press release (Exhibit 99.1) and a Supplemental Earnings Presentation (Exhibit 99.2) as part of the filing. The filing also includes the cover page interactive XBRL data.

Key Details

• Filing date: February 12, 2026 (Form 8‑K).
• Reporting period: Quarter ended December 31, 2025.
• Exhibits furnished: Press release (Exhibit 99.1) and Supplemental Earnings Presentation (Exhibit 99.2).
• Regulation FD: Company disclosed the supplemental earnings presentation under Regulation FD to ensure broad public distribution.

Why It Matters

• This 8‑K signals that Bio‑Rad has released its latest quarterly earnings and related materials — primary sources investors use to evaluate recent revenue, earnings, and operating trends.
• The furnished press release and presentation are the official, company-provided summaries of results and typically include figures and management commentary; investors should review those exhibits for the concrete revenue and profit metrics and any updated guidance.
• Regulation FD disclosure and the included XBRL data mean the information was provided publicly and in a machine-readable format for analysts and investors to verify and model the company’s reported results.